NCT04174261View on ClinicalTrials.gov

Ticagrelor in Remote Ischemic Preconditioning Study

PHASE4CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

January 29, 2017

Primary Completion Date

December 18, 2017

Study Completion Date

January 17, 2018

Conditions
Periprocedural Myocardial Infarction
Interventions
DRUG

Ticagrelor

Preprocedural ticagrelor loading and standard dose thereafter

PROCEDURE

Remote Ischemic Preconditioning

Preprocedural remote ischemic preconditioning on the non-dominant arm

DRUG

Clopidogrel

Preprocedural clopidogrel loading and standard dose thereafter

Trial Locations (1)

11526

Athens Red Cross Hospital, Athens

All Listed Sponsors
lead

Hellenic Society of Interventional Cardiology

OTHER

NCT04174261 - Ticagrelor in Remote Ischemic Preconditioning Study | Biotech Hunter | Biotech Hunter